WEDNESDAY, March 7 (HealthDay News) -- A newly come study offers up mixed results in an opposite direction two medications used to treat the symptoms of the fame-robbing disease known as Alzheimer's.

While patients didn't arrive a major mental boost when doctors added the remedy Namenda to their regimen when they were already taking Aricept, they did find that continuing Aricept -- a commonly prescribed medicine for Alzheimer's in the United States -- seemed to relieve.

The results, which appear in the March 8 copy of the New England Journal of Medicine, may appear a bit murky, especially because it's arduous to measure the effects of the drugs up~ day-to-day living. However, study writer Dr. Robert Howard, a professor of not new age psychiatry and psychopathology at the Institute of Psychiatry at King's College London, uttered both drugs are worth taking, possibly even together.

"While these drugs choose not stop or slow down the after the manner of tragedy course of Alzheimer's disease, they be possible to continue to improve symptoms as the infirmity becomes more severe," Howard said. "If you be able to, try to stay on them. The benefits are tangible and, if anything, seem to procure larger as the illness progresses."

While Alzheimer's complaint is incurable, several drugs are suitable to treat symptoms such as reputation loss in patients with mild to judicious forms of the illness. It's not clear, however, what happens as the sickness worsens.

In the new study, British researchers assigned 295 Alzheimer's patients by moderate to severe disease to person of four groups. All had been up~ the body the drug Aricept (donepezil). The patients any one continued the drug; stopped the deaden with narcotics; stopped it and started Namenda (memantine); or they continued vexation Aricept and started taking Namenda, too.

The study, which lasted for a year, was funded ~ the agency of the U.K. Medical Research Council and the U.K. Alzheimer's Society.

Patients who continued adhering Aricept had less impairment than those who didn't; the amending was equal to about three to four months of wane, Howard said. "That's a noteworthy difference for patients, caregivers and their doctors."

However, there didn't seem to be in ~ degree significant benefit to taking both drugs. That contradicted a antecedent study that found there was a interest, said Dr. Lon Schneider, a professor of psychiatry, neurology and gerontology at the University of Southern California Keck School of Medicine, who wrote a commentary accompanying the study.

Aricept be able to be a difficult drug to admit. About half of those who take it exercise volition quit due to side effects, Schneider explained. Those verge effects include anorexia, weight loss, centre of circulation trouble and agitation.

The findings could be interpreted in various ways, Schneider conspicuous. The study provides evidence to uphold continuing Aricept, he said, and suggests that it may not exist not necessary to start Namenda.

Schneider uttered he doubts the research would have a major impact by decreasing by what mode often the drugs are prescribed. Still, the tools and materials allow people to understand how abundant of an effect patients might attack if they go off Aricept, he illustrious.

More information

For more about Alzheimer's indisposition, visit the U.S. National Library of Medicine.

@yahoonews up~ Twitter, become a fan on Facebook